The cannabis industry is on the verge of another significant evolutionary step. It is well understood that cannabis can be useful as a personalized medicine, but the details of which ratios of each cannabinoid are ideal for any person are still mysterious. People are getting results from this plant and know to speak about THC and CBD, however these cannabinoids only represent some of cannabis’s potential. Minor cannabinoids like Cannabichromene (CBC), Cannabigerol (CBG), and Cannabinol (CBN) are already earning attention as specialized options with varying effects.
CBC, CBG, and CBN were discovered decades ago, but human research on the effects of their isolate forms is minimal. At the time of this writing, most published studies reflect the effects on animals, so the industry is relying on consumer anecdotes and word of mouth. Most cannabinoids have similar chemical characteristics in how they bind to our bodies’ receptors. The resulting biological changes are not the same though, as each compound has a few trademarks worth discussing further.